Declaración de posición del Grupo de la Comisión Lancet de Hipertensión con respecto a la mejora mundial de las normas de exactitud para los dispositivos de medición de la presión arterial

Translated title of the contribution: Lancet commission on hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

James E. Sharman, Eoin O'Brien, Bruce Alpert, Aletta E. Schutte, Christian Delles, Michael Hecht Olsen, Roland Asmar, Neil Atkins, Eduardo Barbosa, David Calhoun, Norm R.C. Campbell, John Chalmers, Ivor Benjamin, Garry Jennings, Stéphane Laurent, Pierre Boutouyrie, Patricio Lopez-Jaramillo, Richard J. McManus, Anastasia S. Mihailidou, Pedro OrdunezRaj Padwal, Paolo Palatini, Gianfranco Parati, Neil Poulter, Michael K. Rakotz, Clive Rosendorff, Francesca Saladini, Angelo Scuteri, Weimar Sebba Barroso, Myeong Chan Cho, Ki Chul Sung, Raymond R. Townsend, Ji Guang Wang, Tine Willum Hansen, Gregory Wozniak, George Stergiou

Research output: Contribution to journalArticle

Abstract

© 2020 Pan American Health Organization. All rights reserved. The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3 000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation. In addition, new BP technologies have emerged (e.g. cuffless sensors) for which there is no scientific consensus regarding BP measurement accuracy standards. Altogether, these issues contribute to the widespread availability of clinic and home BP devices with limited or uncertain accuracy, leading to inappropriate hypertension diagnosis, management and drug treatment on a global scale. The most significant problems relating to the accuracy of BP devices can be resolved by the regulatory requirement for mandatory independent validation of BP devices according to the universally-accepted International Organization for Standardization Standard. This is a primary recommendation for which there is an urgent international need. Other key recommendations are development of validation standards specifically for new BP technologies and online lists of accurate devices that are accessible to consumers and health professionals. Recommendations are aligned with WHO policies on medical devices and universal healthcare. Adherence to recommendations would increase the global availability of accurate BP devices and result in better diagnosis and treatment of hypertension, thus decreasing the worldwide burden from high BP.
Translated title of the contributionLancet commission on hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure
Original languageSpanish
Article numbere21
Number of pages11
JournalRevista Panamericana de Salud Publica/Pan American Journal of Public Health
Volume44
DOIs
Publication statusPublished - 1 Jan 2020
Externally publishedYes

Bibliographical note

Este es un artículo de acceso abierto distribuido bajo los términos de la licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CCBY-NC-ND), que permite su descarga y distribución siempre que el trabajo original se cite de la manera adecuada. No se permiten modificaciones a los artículos ni su uso comercial. Al reproducir un artículo no debe haber ningún indicio de que la OPS o el artículo avalan a una organización o un producto específico. El uso del logo de la OPS no está permitido. Esta leyenda debe conservarse, junto con la URL original del artículo

Keywords

  • Biomedical technology
  • Diagnostic equipment
  • International health
  • Reference standard

Fingerprint Dive into the research topics of 'Lancet commission on hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure'. Together they form a unique fingerprint.

  • Cite this

    Sharman, J. E., O'Brien, E., Alpert, B., Schutte, A. E., Delles, C., Olsen, M. H., Asmar, R., Atkins, N., Barbosa, E., Calhoun, D., Campbell, N. R. C., Chalmers, J., Benjamin, I., Jennings, G., Laurent, S., Boutouyrie, P., Lopez-Jaramillo, P., McManus, R. J., Mihailidou, A. S., ... Stergiou, G. (2020). Declaración de posición del Grupo de la Comisión Lancet de Hipertensión con respecto a la mejora mundial de las normas de exactitud para los dispositivos de medición de la presión arterial. Revista Panamericana de Salud Publica/Pan American Journal of Public Health, 44, [e21]. https://doi.org/10.26633/RPSP.2020.21